OCULAR THERAPEUTIX, INC Quarterly Nonoperating Income (Expense) in USD from Q2 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Ocular Therapeutix, Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2013 to Q2 2024.
  • Ocular Therapeutix, Inc Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$187K, a 67% decline year-over-year.
  • Ocular Therapeutix, Inc Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$23.9M, a 256% decline year-over-year.
  • Ocular Therapeutix, Inc annual Nonoperating Income (Expense) for 2023 was $1.65M, a 78.4% decline from 2022.
  • Ocular Therapeutix, Inc annual Nonoperating Income (Expense) for 2022 was $7.62M, a 89.3% decline from 2021.
  • Ocular Therapeutix, Inc annual Nonoperating Income (Expense) for 2021 was $71.5M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$23.9M -$187K -$75K -67% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$23.8M -$33.2M -$25.5M -328% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $1.65M -$9.17M -$13M -340% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 $14.6M $18.7M +$21.3M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$6.71M -$112K -$1.26M -110% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$5.44M -$7.77M -$13.1M -247% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $7.62M $3.82M -$10.4M -73.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 $18M -$2.64M -$24.8M -112% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $42.8M $1.15M -$10.6M -90.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $53.4M $5.29M -$18.1M -77.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $71.5M $14.2M +$85.5M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-11
Q3 2021 -$14M $22.2M +$20.1M +976% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$34.1M $11.8M +$30.4M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$64.5M $23.3M +$28.2M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$92.8M -$71.3M -$66.7M -1444% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-06
Q3 2020 -$26.1M $2.06M -$2.3M -52.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$23.8M -$18.7M -$15.8M -555% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$8M -$4.9M -$7.43M -293% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$570K -$4.62M -$4.5M -3879% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $3.93M $4.37M +$4.56M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$630K -$2.85M -$2.61M -1089% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $1.98M $2.53M +$2.84M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 -$860K -$116K +$270K +69.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$1.13M -$194K +$177K +47.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$1.31M -$240K +$115K +32.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$1.42M -$310K +$41K +11.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$1.46M -$386K -$36K -10.3% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-12
Q3 2017 -$1.43M -$371K -$13K -3.63% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$1.41M -$355K -$17K -5.03% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$1.4M -$351K -$20K -6.04% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 -$1.38M -$350K +$12K +3.32% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-07
Q3 2016 -$1.39M -$358K -$8K -2.29% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$1.38M -$338K +$36K +9.63% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$1.42M -$331K +$134K +28.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 -$1.55M -$362K +$45K +11.1% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-08
Q3 2015 -$1.6M -$350K +$168K +32.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$1.76M -$374K +$72K +16.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$1.84M -$465K -$282K -154% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$1.55M -$407K Oct 1, 2014 Dec 31, 2014 10-K 2017-03-10
Q3 2014 -$518K -$431K -495% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 -$446K -$345K -342% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$183K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q3 2013 -$87K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$101K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.